Original Article | Open Access

Causal relationships among seven cardiovascular-associated metabolic diseases: insights from a bidirectional Mendelian randomization study

Views:  18
Metab Target Organ Damage 2025;5:[Accepted].
Author Information
Article Notes
Cite This Article

Abstract

Aim: Previous studies have suggested that metabolic diseases are gene- and heritability-related and there are potential cross genetic correlations. We aim to elucidate the causal relationships among specific metabolic diseases.

 

Methods: We investigated seven metabolic diseases by analyzing summary statistics from Genome-Wide Association Studies (GWASs). Genetic correlations and pleiotropic associations were identified, and biological functions were determined. In addition, two-sample bidirectional Mendelian randomization (MR) analysis was performed to establish causal inferences.

 

Results: Most metabolic diseases shared common genetic components, and more than sixty percent of paired disorders presented significant positive genetic correlations. The primary MR analysis revealed that obesity causally induced higher risk of type 2 diabetes (T2D). Both obesity and T2D increased the risk of hypertension, gout and high triglyceride (TG) levels, whereas gout and TG could pose direct risks for hypertension. Significant differential expression of pleiotropic genes was found in the adrenal gland and brain, and the most enriched tissues were the pancreas, liver and heart.

 

Conclusion: This study identified causal relationships among a set of metabolic diseases and indicated potential mechanisms of disease comorbidities. These findings underscore the need for integrative strategies for metabolic disease management and provide insights for future development of targeted medical therapy.

Keywords

Metabolic disease, causality, pleiotropy, genetics, mendelian randomization

Cite This Article

Lai Z, Liu Z, Wang X, Jiang X, Yang Y, Fan X, Shi Y,  Li X. Causal relationships among seven cardiovascular-associated metabolic diseases: insights from a bidirectional Mendelian randomization study. Metab Target Organ Damage 2025;5:[Accept]. http://dx.doi.org/10.20517/mtod.2025.20

Copyright

...
© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Cite This Article 2 clicks
Share This Article
Scan the QR code for reading!
See Updates
Hot Topics
metabolic syndrome | kidney | atherosclerosis | endocrine disorder | NAFLD | diabetes | MAFLD | adipose tissue | obesity | obesity | metabolism | fatty liver | steatosis | fibrosis | cardiovascular | insulin resistance | hypertension | metabolomics | precision medicine | hypertriglyceridemia |
Metabolism and Target Organ Damage
ISSN 2769-6375 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/